Our previous work already suggested that CD68+ TAMs can support tumor angiogenesis, primarily before NAC, while stabilin-1+ TAMs rather contribute to the maintenance of lymphatic vessel density after NAC [94]. The gene discussed is CD68; the disease is neoplasm.